1 | A bill to be entitled |
2 | An act relating to Medicaid; amending s. 409.912, F.S.; |
3 | authorizing the Agency for Health Care Administration, in |
4 | collaboration with the Department of Health, to develop a |
5 | home and community-based services Medicaid waiver program |
6 | to serve children diagnosed with Trisomy 18, subject to |
7 | federal waiver approval; providing rulemaking authority; |
8 | providing an effective date. |
9 |
|
10 | Be It Enacted by the Legislature of the State of Florida: |
11 |
|
12 | Section 1. Subsection (54) is added to section 409.912, |
13 | Florida Statutes, to read: |
14 | 409.912 Cost-effective purchasing of health care.-The |
15 | agency shall purchase goods and services for Medicaid recipients |
16 | in the most cost-effective manner consistent with the delivery |
17 | of quality medical care. To ensure that medical services are |
18 | effectively utilized, the agency may, in any case, require a |
19 | confirmation or second physician's opinion of the correct |
20 | diagnosis for purposes of authorizing future services under the |
21 | Medicaid program. This section does not restrict access to |
22 | emergency services or poststabilization care services as defined |
23 | in 42 C.F.R. part 438.114. Such confirmation or second opinion |
24 | shall be rendered in a manner approved by the agency. The agency |
25 | shall maximize the use of prepaid per capita and prepaid |
26 | aggregate fixed-sum basis services when appropriate and other |
27 | alternative service delivery and reimbursement methodologies, |
28 | including competitive bidding pursuant to s. 287.057, designed |
29 | to facilitate the cost-effective purchase of a case-managed |
30 | continuum of care. The agency shall also require providers to |
31 | minimize the exposure of recipients to the need for acute |
32 | inpatient, custodial, and other institutional care and the |
33 | inappropriate or unnecessary use of high-cost services. The |
34 | agency shall contract with a vendor to monitor and evaluate the |
35 | clinical practice patterns of providers in order to identify |
36 | trends that are outside the normal practice patterns of a |
37 | provider's professional peers or the national guidelines of a |
38 | provider's professional association. The vendor must be able to |
39 | provide information and counseling to a provider whose practice |
40 | patterns are outside the norms, in consultation with the agency, |
41 | to improve patient care and reduce inappropriate utilization. |
42 | The agency may mandate prior authorization, drug therapy |
43 | management, or disease management participation for certain |
44 | populations of Medicaid beneficiaries, certain drug classes, or |
45 | particular drugs to prevent fraud, abuse, overuse, and possible |
46 | dangerous drug interactions. The Pharmaceutical and Therapeutics |
47 | Committee shall make recommendations to the agency on drugs for |
48 | which prior authorization is required. The agency shall inform |
49 | the Pharmaceutical and Therapeutics Committee of its decisions |
50 | regarding drugs subject to prior authorization. The agency is |
51 | authorized to limit the entities it contracts with or enrolls as |
52 | Medicaid providers by developing a provider network through |
53 | provider credentialing. The agency may competitively bid single- |
54 | source-provider contracts if procurement of goods or services |
55 | results in demonstrated cost savings to the state without |
56 | limiting access to care. The agency may limit its network based |
57 | on the assessment of beneficiary access to care, provider |
58 | availability, provider quality standards, time and distance |
59 | standards for access to care, the cultural competence of the |
60 | provider network, demographic characteristics of Medicaid |
61 | beneficiaries, practice and provider-to-beneficiary standards, |
62 | appointment wait times, beneficiary use of services, provider |
63 | turnover, provider profiling, provider licensure history, |
64 | previous program integrity investigations and findings, peer |
65 | review, provider Medicaid policy and billing compliance records, |
66 | clinical and medical record audits, and other factors. Providers |
67 | shall not be entitled to enrollment in the Medicaid provider |
68 | network. The agency shall determine instances in which allowing |
69 | Medicaid beneficiaries to purchase durable medical equipment and |
70 | other goods is less expensive to the Medicaid program than long- |
71 | term rental of the equipment or goods. The agency may establish |
72 | rules to facilitate purchases in lieu of long-term rentals in |
73 | order to protect against fraud and abuse in the Medicaid program |
74 | as defined in s. 409.913. The agency may seek federal waivers |
75 | necessary to administer these policies. |
76 | (54) The agency shall work with the Department of Health |
77 | to develop a home and community-based services Medicaid waiver |
78 | program to serve children diagnosed with Trisomy 18, also known |
79 | as Edwards syndrome, a rare genetic disorder that is |
80 | characterized by heart abnormalities, kidney dysfunction, and |
81 | other internal disorders. The agency shall implement the program |
82 | subject to federal waiver approval, the availability of funds, |
83 | and any limitations provided in the General Appropriations Act. |
84 | The agency may adopt rules to implement this subsection. |
85 | Section 2. This act shall take effect July 1, 2011. |